Literature DB >> 17420232

Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.

Victoria Auerbuch1, Ralph R Isberg.   

Abstract

Pathogenic Yersinia translocates effector proteins into target cells via a type III secretion system (TTSS), modulating the host immune response. A component of the TTSS translocon, LcrV, has been implicated in preventing inflammation through Toll-like receptor 2 (TLR2) by inducing expression of the anti-inflammatory cytokine interleukin-10 (IL-10). TLR2(-/-) mice were reported to be less susceptible to the enteropathogen Yersinia enterocolitica. To determine whether TLR2 also plays a role in recognition of the enteropathogen Yersinia pseudotuberculosis and whether this results in an immune response that is detrimental to the host, we evaluated the macrophage cytokine response to live Y. pseudotuberculosis and analyzed the susceptibility of TLR2(-/-) mice to enteropathogenic Yersinia. We find that Yersinia induction of macrophage IL-10 occurs independently of TLR2 and LcrV and is blocked by the TTSS. In particular, the TTSS effector protein YopJ, which inhibits production of the inflammatory cytokine tumor necrosis factor alpha (TNF-alpha), also inhibits IL-10 expression. Consistent with these results, IL-10 is undetectable in Y. pseudotuberculosis-infected mouse tissues until advanced stages of infection. In addition, we find that TLR2(-/-) mice (derived independently from those used in previous studies) do not display altered susceptibility to enteropathogenic Yersinia compared to wild-type mice. Tissue levels of IL-10, as well as the inflammatory cytokines TNF-alpha, IL-6, and gamma interferon and the chemokine macrophage chemotactic protein 1, are similar in TLR2(+/+) and TLR2(-/-) mice during enteropathogenic Yersinia infection. Therefore, the absence of TLR2 alone does not affect the cytokine response of macrophages to, or the in vivo growth and survival of, enteropathogenic Yersinia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420232      PMCID: PMC1932928          DOI: 10.1128/IAI.01497-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  The Yersinia Yops inhibit invasion of Listeria, Shigella and Edwardsiella but not Salmonella into epithelial cells.

Authors:  J Mecsas; B Raupach; S Falkow
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

2.  Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.

Authors:  A Boland; G R Cornelis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis.

Authors:  E E Galyov; S Håkansson; H Wolf-Watz
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

Review 4.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK.

Authors:  L E Palmer; S Hobbie; J E Galán; J B Bliska
Journal:  Mol Microbiol       Date:  1998-03       Impact factor: 3.501

6.  Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Authors:  Michael L Fisher; Cynthia Castillo; Joan Mecsas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity.

Authors:  K Schesser; A K Spiik; J M Dukuzumuremyi; M F Neurath; S Pettersson; H Wolf-Watz
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

8.  The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.

Authors:  M L Nilles; K A Fields; S C Straley
Journal:  J Bacteriol       Date:  1998-07       Impact factor: 3.490

9.  Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

Authors:  R Nakajima; V L Motin; R R Brubaker
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice.

Authors:  D M Monack; J Mecsas; D Bouley; S Falkow
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  23 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

2.  Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.

Authors:  Jeanette E Bröms; Matthew S Francis; Ake Forsberg
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

3.  Legionella pneumophila EnhC is required for efficient replication in tumour necrosis factor alpha-stimulated macrophages.

Authors:  Mingyu Liu; Gloria M Conover; Ralph R Isberg
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

4.  A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.

Authors:  Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

5.  Evolution and virulence contributions of the autotransporter proteins YapJ and YapK of Yersinia pestis CO92 and their homologs in Y. pseudotuberculosis IP32953.

Authors:  Jonathan D Lenz; Brenda R S Temple; Virginia L Miller
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

6.  Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Authors:  Julie L Boyer; Carolina Sofer-Podesta; John Ang; Neil R Hackett; Maria J Chiuchiolo; Svetlana Senina; David Perlin; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

7.  Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.

Authors:  Youmin Zhong; Angelene Cantwell; Peter H Dube
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

8.  Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Authors:  Joshua K Turner; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.

Authors:  Wei Sun; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-07-24       Impact factor: 3.738

10.  Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Authors:  Agathe Goubard; Caroline Loïez; Jun Abe; Caroline Fichel; Stéphanie Herwegh; Christelle Faveeuw; Rémi Porte; Delphine Cayet; Florent Sebbane; Sylvie Penet; Benoit Foligné; Pierre Desreumaux; Hirohisa Saito; Jean-Claude Sirard; Michel Simonet; Christophe Carnoy
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.